DUBLIN--(BUSINESS WIRE)--The "Drug Addiction Treatment Market Report, by Treatment, by Drug Type, by End User and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The drug addiction treatment market size is estimated to be USD 18.45 billion in 2021 and is expected to witness a CAGR of 8.32% during the forecast period 2022-2029. The increasing patient knowledge, high levels of treatment enrolment, and government's expanding initiatives are the factors contributing to the market growth. However, patent expiration of branded medication is expected to hinder the growth.
Segmentation: Drug Addiction Treatment Market Report 2021-2029By Treatment (Revenue, USD Billion)
- Medicines
- Self Help Groups
- Detoxication
- Rehabilitation Programs
- Counselling & Behavioural Therapies
By Drug Type (Revenue, USD Billion)
- Marijuana
- Synthetic Cannabinoids
- Over the Counter Medications
- Alcohol
- Tobacco/Nicotine & Vaping
By End user (Revenue, USD Billion)
- Speciality Clinics
- Homecare
- Hospitals
By Region (Revenue, USD Billion)North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Drug Addiction Treatment
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Drug Addiction Treatment Market
7. Market Analysis by Treatment
8. Market Analysis by Drug Type
9. Market Analysis by End User
10. Regional Market Analysis
11. North America Drug Addiction Treatment Market
12. Europe Drug Addiction Treatment Market
13. Asia Pacific Drug Addiction Treatment Market
14. Latin America Drug Addiction Treatment Market
15. MEA Drug Addiction Treatment Market
16. Competitor Analysis
17. Company Profiles
18. Conclusion & Recommendations
Companies Mentioned
- Lundbeck A/S
- Teva Pharmaceutical Industries Ltd
- Sosei Group Corporation
- Cv Sciences Inc
- H. Zydus Cadila Cerecor Inc
- Astraea Therapeutics Llc
- Johnson & Johnson Services Inc.
- Glaxosmithkline Plc
- Pfizer Inc
- Sanofi
- Addex Therapeutics
- Omeros Corporation
- Novartis Ag
- Dr. Reddy'S Laboratories Ltd
- Mylan N.V.
- Hager Biosciences Llc
- Axsome Therapeutics Inc
- Glenmark Pharmaceuticals Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/27c66m
